MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 38 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $73,245 | +30.0% | 25,700 | +79.7% | 0.00% | – |
| Q1 2023 | $56,342 | -71.0% | 14,300 | -70.9% | 0.00% | -100.0% |
| Q4 2022 | $194,436 | -0.8% | 49,100 | +37.9% | 0.00% | 0.0% |
| Q2 2021 | $196,000 | -41.7% | 35,600 | -38.7% | 0.00% | 0.0% |
| Q1 2021 | $336,000 | -4.0% | 58,100 | +11.1% | 0.00% | 0.0% |
| Q4 2020 | $350,000 | +343.0% | 52,300 | +150.2% | 0.00% | – |
| Q2 2020 | $79,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |